191 related articles for article (PubMed ID: 22149175)
1. SPANosomes as delivery vehicles for small interfering RNA (siRNA).
Zhou C; Mao Y; Sugimoto Y; Zhang Y; Kanthamneni N; Yu B; Brueggemeier RW; Lee LJ; Lee RJ
Mol Pharm; 2012 Feb; 9(2):201-10. PubMed ID: 22149175
[TBL] [Abstract][Full Text] [Related]
2. Lipoplexes versus nanoparticles: pDNA/siRNA delivery.
Khurana B; Goyal AK; Budhiraja A; Aora D; Vyas SP
Drug Deliv; 2013 Feb; 20(2):57-64. PubMed ID: 23537464
[TBL] [Abstract][Full Text] [Related]
3. siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing.
Cardoso AL; Simões S; de Almeida LP; Pelisek J; Culmsee C; Wagner E; Pedroso de Lima MC
J Gene Med; 2007 Mar; 9(3):170-83. PubMed ID: 17351968
[TBL] [Abstract][Full Text] [Related]
4. Quantitative silencing of EGFP reporter gene by self-assembled siRNA lipoplexes of LinOS and cholesterol.
Metwally AA; Blagbrough IS; Mantell JM
Mol Pharm; 2012 Nov; 9(11):3384-95. PubMed ID: 23057412
[TBL] [Abstract][Full Text] [Related]
5. Design of Ionizable Lipids To Overcome the Limiting Step of Endosomal Escape: Application in the Intracellular Delivery of mRNA, DNA, and siRNA.
Habrant D; Peuziat P; Colombani T; Dallet L; Gehin J; Goudeau E; Evrard B; Lambert O; Haudebourg T; Pitard B
J Med Chem; 2016 Apr; 59(7):3046-62. PubMed ID: 26943260
[TBL] [Abstract][Full Text] [Related]
6. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid.
Kim HK; Davaa E; Myung CS; Park JS
Int J Pharm; 2010 Jun; 392(1-2):141-7. PubMed ID: 20347025
[TBL] [Abstract][Full Text] [Related]
7. Differential efficacy of DOTAP enantiomers for siRNA delivery in vitro.
Terp MC; Bauer F; Sugimoto Y; Yu B; Brueggemeier RW; Lee LJ; Lee RJ
Int J Pharm; 2012 Jul; 430(1-2):328-34. PubMed ID: 22525086
[TBL] [Abstract][Full Text] [Related]
8. Mechanistic profiling of the siRNA delivery dynamics of lipid-polymer hybrid nanoparticles.
Colombo S; Cun D; Remaut K; Bunker M; Zhang J; Martin-Bertelsen B; Yaghmur A; Braeckmans K; Nielsen HM; Foged C
J Control Release; 2015 Mar; 201():22-31. PubMed ID: 25540904
[TBL] [Abstract][Full Text] [Related]
9. Transfection efficiency of lipoplexes for site-directed delivery.
Jellema RK; Bomans P; Deckers N; Ungethum L; Reutelingsperger CP; Hofstra L; Frederik PM
J Liposome Res; 2010 Sep; 20(3):258-67. PubMed ID: 19947825
[TBL] [Abstract][Full Text] [Related]
10. DOTAP functionalizing single-walled carbon nanotubes as non-viral vectors for efficient intracellular siRNA delivery.
Li H; Hao Y; Wang N; Wang L; Jia S; Wang Y; Yang L; Zhang Y; Zhang Z
Drug Deliv; 2016; 23(3):840-8. PubMed ID: 24892622
[TBL] [Abstract][Full Text] [Related]
11. Efficient siRNA delivery using novel siRNA-loaded Bubble liposomes and ultrasound.
Endo-Takahashi Y; Negishi Y; Kato Y; Suzuki R; Maruyama K; Aramaki Y
Int J Pharm; 2012 Jan; 422(1-2):504-9. PubMed ID: 22119963
[TBL] [Abstract][Full Text] [Related]
12. Formulation of Nonionic Surfactant Vesicles (NISV) Prepared by Microfluidics for Therapeutic Delivery of siRNA into Cancer Cells.
Obeid MA; Elburi A; Young LC; Mullen AB; Tate RJ; Ferro VA
Mol Pharm; 2017 Jul; 14(7):2450-2458. PubMed ID: 28570823
[TBL] [Abstract][Full Text] [Related]
13. Development and characterization of a novel cationic PEGylated niosome-encapsulated forms of doxorubicin, quercetin and siRNA for the treatment of cancer by using combination therapy.
Hemati M; Haghiralsadat F; Yazdian F; Jafari F; Moradi A; Malekpour-Dehkordi Z
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1295-1311. PubMed ID: 30033768
[TBL] [Abstract][Full Text] [Related]
14. Ultradeformable cationic liposomes for delivery of small interfering RNA (siRNA) into human primary melanocytes.
Geusens B; Lambert J; De Smedt SC; Buyens K; Sanders NN; Van Gele M
J Control Release; 2009 Feb; 133(3):214-20. PubMed ID: 18973779
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of cationic dendrimer and lipid as transfection reagents of short RNAs for stem cell modification.
Ziraksaz Z; Nomani A; Soleimani M; Bakhshandeh B; Arefian E; Haririan I; Tabbakhian M
Int J Pharm; 2013 May; 448(1):231-8. PubMed ID: 23535347
[TBL] [Abstract][Full Text] [Related]
16. Core-shell type lipid/rPAA-Chol polymer hybrid nanoparticles for in vivo siRNA delivery.
Gao LY; Liu XY; Chen CJ; Wang JC; Feng Q; Yu MZ; Ma XF; Pei XW; Niu YJ; Qiu C; Pang WH; Zhang Q
Biomaterials; 2014 Feb; 35(6):2066-78. PubMed ID: 24315577
[TBL] [Abstract][Full Text] [Related]
17. Peptide-based targeted polymeric nanoparticles for siRNA delivery.
Hussein WM; Cheong YS; Liu C; Liu G; Begum AA; Attallah MA; Moyle PM; Torchilin VP; Smith R; Toth I
Nanotechnology; 2019 Oct; 30(41):415604. PubMed ID: 31295734
[TBL] [Abstract][Full Text] [Related]
18. Liposomal siRNA delivery.
Hughes J; Yadava P; Mesaros R
Methods Mol Biol; 2010; 605():445-59. PubMed ID: 20072900
[TBL] [Abstract][Full Text] [Related]
19. Cationic amphiphilic macromolecule (CAM)-lipid complexes for efficient siRNA gene silencing.
Gu L; Nusblat LM; Tishbi N; Noble SC; Pinson CM; Mintzer E; Roth CM; Uhrich KE
J Control Release; 2014 Jun; 184():28-35. PubMed ID: 24727076
[TBL] [Abstract][Full Text] [Related]
20. Self-assembled lamellar complexes of siRNA with lipidic aminoglycoside derivatives promote efficient siRNA delivery and interference.
Desigaux L; Sainlos M; Lambert O; Chevre R; Letrou-Bonneval E; Vigneron JP; Lehn P; Lehn JM; Pitard B
Proc Natl Acad Sci U S A; 2007 Oct; 104(42):16534-9. PubMed ID: 17923669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
